Global and United States Pazopanib Market Report & Forecast 2024-2031

Report ID: 1869267 | Published Date: Jan 2025 | No. of Page: 79 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Pazopanib Product Introduction
    1.2 Global Pazopanib Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Pazopanib Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Pazopanib Sales in Volume for the Year 2017-2028
    1.3 United States Pazopanib Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Pazopanib Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Pazopanib Sales in Volume for the Year 2017-2028
    1.4 Pazopanib Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Pazopanib in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Pazopanib Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Pazopanib Market Dynamics
        1.5.1 Pazopanib Industry Trends
        1.5.2 Pazopanib Market Drivers
        1.5.3 Pazopanib Market Challenges
        1.5.4 Pazopanib Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Pazopanib Market Segment by Type
        2.1.1 200mg Tables
        2.1.2 400mg Tables
    2.2 Global Pazopanib Market Size by Type
        2.2.1 Global Pazopanib Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Pazopanib Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Pazopanib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Pazopanib Market Size by Type
        2.3.1 United States Pazopanib Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Pazopanib Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Pazopanib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Pazopanib Market Segment by Application
        3.1.1 Renal Cell Carcinoma
        3.1.2 Soft Tissue Sarcoma
        3.1.3 Other
    3.2 Global Pazopanib Market Size by Application
        3.2.1 Global Pazopanib Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Pazopanib Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Pazopanib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Pazopanib Market Size by Application
        3.3.1 United States Pazopanib Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Pazopanib Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Pazopanib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Pazopanib Competitor Landscape by Company
    4.1 Global Pazopanib Market Size by Company
        4.1.1 Top Global Pazopanib Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Pazopanib Revenue by Manufacturer (2017-2022)
        4.1.3 Global Pazopanib Sales by Manufacturer (2017-2022)
        4.1.4 Global Pazopanib Price by Manufacturer (2017-2022)
    4.2 Global Pazopanib Concentration Ratio (CR)
        4.2.1 Pazopanib Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pazopanib in 2021
        4.2.3 Global Pazopanib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Pazopanib Manufacturing Base Distribution, Product Type
        4.3.1 Global Pazopanib Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Pazopanib Product Type
        4.3.3 Date of International Manufacturers Enter into Pazopanib Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Pazopanib Market Size by Company
        4.5.1 Top Pazopanib Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Pazopanib Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Pazopanib Sales by Players (2020, 2021 & 2022)
5 Global Pazopanib Market Size by Region
    5.1 Global Pazopanib Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Pazopanib Market Size in Volume by Region (2017-2028)
        5.2.1 Global Pazopanib Sales in Volume by Region: 2017-2022
        5.2.2 Global Pazopanib Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Pazopanib Market Size in Value by Region (2017-2028)
        5.3.1 Global Pazopanib Sales in Value by Region: 2017-2022
        5.3.2 Global Pazopanib Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Pazopanib Market Size YoY Growth 2017-2028
        6.1.2 North America Pazopanib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Pazopanib Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Pazopanib Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Pazopanib Market Size YoY Growth 2017-2028
        6.3.2 Europe Pazopanib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Pazopanib Market Size YoY Growth 2017-2028
        6.4.2 Latin America Pazopanib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Pazopanib Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Pazopanib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Corporation Information
        7.1.2 Novartis Description and Business Overview
        7.1.3 Novartis Pazopanib Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Novartis Pazopanib Products Offered
        7.1.5 Novartis Recent Development
    7.2 GlaxoSmithKline
        7.2.1 GlaxoSmithKline Corporation Information
        7.2.2 GlaxoSmithKline Description and Business Overview
        7.2.3 GlaxoSmithKline Pazopanib Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 GlaxoSmithKline Pazopanib Products Offered
        7.2.5 GlaxoSmithKline Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Pazopanib Industry Chain Analysis
    8.2 Pazopanib Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Pazopanib Distributors
    8.3 Pazopanib Production Mode & Process
    8.4 Pazopanib Sales and Marketing
        8.4.1 Pazopanib Sales Channels
        8.4.2 Pazopanib Distributors
    8.5 Pazopanib Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Pazopanib CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Pazopanib Market Trends
    Table 3. Pazopanib Market Drivers
    Table 4. Pazopanib Market Challenges
    Table 5. Pazopanib Market Restraints
    Table 6. Global Pazopanib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Pazopanib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Pazopanib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Pazopanib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Pazopanib Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Pazopanib Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Pazopanib Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Pazopanib Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Pazopanib Sales Share by Manufacturer, 2017-2022
    Table 15. Global Pazopanib Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Pazopanib Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Pazopanib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pazopanib as of 2021)
    Table 18. Top Players of Pazopanib in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Pazopanib Product Type
    Table 20. Date of International Manufacturers Enter into Pazopanib Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Pazopanib Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Pazopanib Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Pazopanib Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Pazopanib Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Pazopanib Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Pazopanib Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Pazopanib Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Pazopanib Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Pazopanib Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Pazopanib Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Pazopanib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Pazopanib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Pazopanib Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Pazopanib Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Pazopanib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Pazopanib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Pazopanib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Pazopanib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Pazopanib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Pazopanib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Novartis Corporation Information
    Table 43. Novartis Description and Business Overview
    Table 44. Novartis Pazopanib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Novartis Pazopanib Product
    Table 46. Novartis Recent Development
    Table 47. GlaxoSmithKline Corporation Information
    Table 48. GlaxoSmithKline Description and Business Overview
    Table 49. GlaxoSmithKline Pazopanib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. GlaxoSmithKline Product
    Table 51. GlaxoSmithKline Recent Development
    Table 52. Key Raw Materials Lists
    Table 53. Raw Materials Key Suppliers Lists
    Table 54. Pazopanib Customers List
    Table 55. Pazopanib Distributors List
    Table 56. Research Programs/Design for This Report
    Table 57. Key Data Information from Secondary Sources
    Table 58. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pazopanib Product Picture
    Figure 2. Global Pazopanib Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Pazopanib Market Size 2017-2028 (US$ Million)
    Figure 4. Global Pazopanib Sales 2017-2028 (K Pcs)
    Figure 5. United States Pazopanib Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Pazopanib Market Size 2017-2028 (US$ Million)
    Figure 7. United States Pazopanib Sales 2017-2028 (K Pcs)
    Figure 8. United States Pazopanib Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Pazopanib Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Pazopanib Report Years Considered
    Figure 11. Product Picture of 200mg Tables
    Figure 12. Product Picture of 400mg Tables
    Figure 13. Global Pazopanib Market Share by Type in 2022 & 2028
    Figure 14. Global Pazopanib Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Pazopanib Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Pazopanib Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Pazopanib Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Pazopanib Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Pazopanib Market Share by Type in 2022 & 2028
    Figure 20. United States Pazopanib Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Pazopanib Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Pazopanib Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Pazopanib Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Pazopanib Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Renal Cell Carcinoma
    Figure 26. Product Picture of Soft Tissue Sarcoma
    Figure 27. Product Picture of Other
    Figure 28. Global Pazopanib Market Share by Application in 2022 & 2028
    Figure 29. Global Pazopanib Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Pazopanib Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Pazopanib Sales by Application (2017-2028) & (K Pcs)
    Figure 32. Global Pazopanib Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Pazopanib Price by Application (2017-2028) & (USD/Pcs)
    Figure 34. United States Pazopanib Market Share by Application in 2022 & 2028
    Figure 35. United States Pazopanib Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Pazopanib Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Pazopanib Sales by Application (2017-2028) & (K Pcs)
    Figure 38. United States Pazopanib Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Pazopanib Price by Application (2017-2028) & (USD/Pcs)
    Figure 40. North America Pazopanib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 41. North America Pazopanib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Pazopanib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 45. Europe Pazopanib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Pazopanib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 52. Asia-Pacific Pazopanib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Pazopanib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 64. Latin America Pazopanib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Pazopanib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 69. Middle East & Africa Pazopanib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Pazopanib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Pazopanib Value Chain
    Figure 74. Pazopanib Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
GlaxoSmithKline
Frequently Asked Questions
Pazopanib report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pazopanib report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pazopanib report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Rilpivirine

Rilpivirine market is segmented by region (country), players, by Type and by Application. Players ... Read More

Ceritinib

Ceritinib market is segmented by region (country), players, by Type and by Application. Players,  ... Read More